VaramirStart free · no cardSign in
RXRX as of Oct 31 · 20:02 ET
RXRXNasdaqBiological Products, (No Diagnostic Substances)

Recursion Pharmaceuticals, Inc. · Brief

Next report

3 days

Nov 4 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±11.1%
avg realized
±4.7%
Nov 6 '24±10.7%▼−0.57%×0.05
Feb 28 '25±11.5%▼−2.09%×0.18
May 5 '25±12.4%▼−16.58%×1.34
Aug 5 '25±11.4%▼−4.66%×0.41
Q3 FY25±11.1%▼−0.80%×0.07
Q1 FY26±8.4%▲+6.80%×0.81
May 6 '26±8.9%▲+1.78%×0.20
Q2 FY26±14.1%▼−4.23%×0.30
quarterimplied−20%0+20%realized×
Q2 FY26±14.1%▼−4.23%×0.30
May '26±8.9%▲+1.78%×0.20
Q1 FY26±8.4%▲+6.80%×0.81
Q3 FY25±11.1%▼−0.80%×0.07
Aug '25±11.4%▼−4.66%×0.41
May '25±12.4%▼−16.58%×1.34
2 older reports
Feb '25±11.5%▼−2.09%×0.18
Nov '24±10.7%▼−0.57%×0.05
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 3

14disclosed supplier and customer ties in SEC filingsSEC filings
+12.88%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

7 of 8recent reports where the move came in under the options implied rangeEarnings history
4 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

RXRX report session

Suppliers 2

NVDANvidia×0.19GOOGLGoogle Cloud×0.12
× = co-movement · max 499dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±16.8% into Nov 4 earnings (Oct 21 close).Source
Oct 158-KMaterial agreement: underwriting agreement with Leerink Partners LLC, Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and Evercore…Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.